- Home
- EBS vs XNET Comparison
EBS vs XNET Comparison
Compare EBS & XNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- XNET
- Stock Information
- Founded
- EBS 1998
- XNET 2003
- Country
- EBS United States
- XNET China
- Employees
- EBS N/A
- XNET N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- XNET Computer Software: Prepackaged Software
- Sector
- EBS Health Care
- XNET Technology
- Exchange
- EBS Nasdaq
- XNET Nasdaq
- Market Cap
- EBS 359.3M
- XNET 373.0M
- IPO Year
- EBS 2006
- XNET 2014
- Fundamental
- Price
- EBS $9.23
- XNET $7.21
- Analyst Decision
- EBS Strong Buy
- XNET
- Analyst Count
- EBS 3
- XNET 0
- Target Price
- EBS $14.33
- XNET N/A
- AVG Volume (30 Days)
- EBS 1.5M
- XNET 1.5M
- Earning Date
- EBS 08-06-2025
- XNET 08-14-2025
- Dividend Yield
- EBS N/A
- XNET N/A
- EPS Growth
- EBS N/A
- XNET 5056.12
- EPS
- EBS 2.53
- XNET 11.50
- Revenue
- EBS $851,600,000.00
- XNET $355,826,000.00
- Revenue This Year
- EBS N/A
- XNET N/A
- Revenue Next Year
- EBS $14.20
- XNET N/A
- P/E Ratio
- EBS $3.65
- XNET $0.63
- Revenue Growth
- EBS N/A
- XNET 11.15
- 52 Week Low
- EBS $4.02
- XNET $1.51
- 52 Week High
- EBS $12.73
- XNET $8.80
- Technical
- Relative Strength Index (RSI)
- EBS 68.42
- XNET 64.93
- Support Level
- EBS $8.91
- XNET $6.92
- Resistance Level
- EBS $9.43
- XNET $8.80
- Average True Range (ATR)
- EBS 0.59
- XNET 0.48
- MACD
- EBS 0.15
- XNET 0.29
- Stochastic Oscillator
- EBS 88.89
- XNET 64.03
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About XNET Xunlei Limited
Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.